SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wintac receives Termination Letter from Par Formulations

01 Mar 2019 Evaluate

Wintac has received a Termination Letter from Par Formulations notifying the termination of Business Transfer Agreement for non-fulfillment by Par Formulations and Wintac of certain conditions within the stipulated time limits, while reserving all of Buyer's rights, powers, privileges, remedies and defenses.

Earlier, the company had entered into a Business Transfer Agreement with Par Formulations on April 26, 2018 for the sale of Pharmaceutical Business Undertaking of the Company.

Wintac is a professionally managed and fully integrated pharmaceutical company that is committed in developing, manufacturing and marketing of high quality pharmaceutical formulations using innovative technologies and meeting the cGMP standards which are continuously updated to international requirements.

Wintac Share Price

341.60 0.00 (0.00%)
17-Dec-2020 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×